Jefferies downgrades Alnylam stock rating on valuation concerns

🇺🇸 Investing.com (US) —
Jefferies downgrades Alnylam stock rating on valuation concerns

AI Summary

Jefferies has downgraded its stock rating on Alnylam Pharmaceuticals due to valuation concerns. The downgrade signals that analysts believe the stock may be overpriced relative to its current fundamentals.

Markets Deals Health Alnylam Pharmaceuticals Jefferies stock downgrade biotech pharma valuation equity research

Read original source →